Influence of Long-Term Continuous Intravenous Administration of Pentoxifylline on Endothelial-Related Coagulation in Critically Ill Patients: Retraction
- PMID: 37589536
- DOI: 10.1097/CCM.0000000000005911
Influence of Long-Term Continuous Intravenous Administration of Pentoxifylline on Endothelial-Related Coagulation in Critically Ill Patients: Retraction
Retraction of
-
Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients.Crit Care Med. 1996 Jun;24(6):940-6. doi: 10.1097/00003246-199606000-00011. Crit Care Med. 1996. Retraction in: Crit Care Med. 2023 Sep 1;51(9):e199. doi: 10.1097/CCM.0000000000005911. PMID: 8681595 Retracted. Clinical Trial.
References
-
- Boldt J, Müller M, Heyn S, et al.: Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients. Crit Care Med. 1996; 24:940–946
-
- Wiedermann CJ: Further retractions of articles by Joachim Boldt. Crit Care Med. 2022; 50:e601–e603
-
- Mukherjee J: Statement on the scientific credibility of articles published by Dr. Joachim Boldt, formerly professor at Justus Liebig University (JLU), Giessen, Germany, 2018. Available at: https://ars.els-cdn.com/content/image/1-s2.0-S000709122030163Xmmc3.pdf . Accessed February 13, 2023
-
- Bleck TP, Buchman TG, Chang CWJ, et al.: The authors reply. Crit Care Med. 2022; 50:e604–e606
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
